These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 11274421)
1. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Hiemstra HS; Schloot NC; van Veelen PA; Willemen SJ; Franken KL; van Rood JJ; de Vries RR; Chaudhuri A; Behan PO; Drijfhout JW; Roep BO Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3988-91. PubMed ID: 11274421 [TBL] [Abstract][Full Text] [Related]
2. Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus. Roep BO; Hiemstra HS; Schloot NC; De Vries RR; Chaudhuri A; Behan PO; Drijfhout JW Ann N Y Acad Sci; 2002 Apr; 958():163-5. PubMed ID: 12021098 [TBL] [Abstract][Full Text] [Related]
3. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient. Schloot NC; Batstra MC; Duinkerken G; De Vries RR; Dyrberg T; Chaudhuri A; Behan PO; Roep BO J Autoimmun; 1999 Jun; 12(4):289-96. PubMed ID: 10330300 [TBL] [Abstract][Full Text] [Related]
4. Differential presentation of glutamic acid decarboxylase 65 (GAD65) T cell epitopes among HLA-DRB1*0401-positive individuals. Reijonen H; Elliott JF; van Endert P; Nepom G J Immunol; 1999 Aug; 163(3):1674-81. PubMed ID: 10415074 [TBL] [Abstract][Full Text] [Related]
5. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242 [TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome. Skorstad G; Hestvik AL; Vartdal F; Holmøy T J Autoimmun; 2009 Feb; 32(1):24-32. PubMed ID: 19027267 [TBL] [Abstract][Full Text] [Related]
8. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Baekkeskov S; Aanstoot HJ; Christgau S; Reetz A; Solimena M; Cascalho M; Folli F; Richter-Olesen H; De Camilli P Nature; 1990 Sep; 347(6289):151-6. PubMed ID: 1697648 [TBL] [Abstract][Full Text] [Related]
9. Modulation of autoimmunity to beta-cell antigens by proteases. Roep BO; van den Engel NK; van Halteren AG; Duinkerken G; Martin S Diabetologia; 2002 May; 45(5):686-92. PubMed ID: 12107749 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects. Danke NA; Yang J; Greenbaum C; Kwok WW J Autoimmun; 2005 Dec; 25(4):303-11. PubMed ID: 16249070 [TBL] [Abstract][Full Text] [Related]
11. Establishment of an expression cloning system for CD4+ T cell epitopes. Fujii S; Uemura Y; Iwai LK; Ando M; Senju S; Nishimura Y Biochem Biophys Res Commun; 2001 Jun; 284(5):1140-7. PubMed ID: 11414702 [TBL] [Abstract][Full Text] [Related]
12. CD8+ suppressor-mediated regulation of human CD4+ T cell responses to glutamic acid decarboxylase 65. James EA; Kwok WW Eur J Immunol; 2007 Jan; 37(1):78-86. PubMed ID: 17163450 [TBL] [Abstract][Full Text] [Related]
13. T cells to a dominant epitope of GAD65 express a public CDR3 motif. Quinn A; McInerney M; Huffman D; McInerney B; Mayo S; Haskins K; Sercarz E Int Immunol; 2006 Jun; 18(6):967-79. PubMed ID: 16641112 [TBL] [Abstract][Full Text] [Related]
14. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. Schwartz HL; Chandonia JM; Kash SF; Kanaani J; Tunnell E; Domingo A; Cohen FE; Banga JP; Madec AM; Richter W; Baekkeskov S J Mol Biol; 1999 Apr; 287(5):983-99. PubMed ID: 10222205 [TBL] [Abstract][Full Text] [Related]
15. Low-avidity recognition by CD4+ T cells directed to self-antigens. Gebe JA; Falk BA; Rock KA; Kochik SA; Heninger AK; Reijonen H; Kwok WW; Nepom GT Eur J Immunol; 2003 May; 33(5):1409-17. PubMed ID: 12731068 [TBL] [Abstract][Full Text] [Related]
16. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes. Oling V; Reijonen H; Simell O; Knip M; Ilonen J Cell Immunol; 2012; 273(2):133-9. PubMed ID: 22270037 [TBL] [Abstract][Full Text] [Related]
17. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Ramirez-Montealegre D; Chattopadhyay S; Curran TM; Wasserfall C; Pritchard L; Schatz D; Petitto J; Hopkins D; She JX; Rothberg PG; Atkinson M; Pearce DA Neurology; 2005 Feb; 64(4):743-5. PubMed ID: 15728308 [TBL] [Abstract][Full Text] [Related]
18. Autoimmune mechanisms in type 1 diabetes. Knip M; Siljander H Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444 [TBL] [Abstract][Full Text] [Related]
19. Characterisation of an autoreactive conformational epitope on GAD65 recognised by the human monoclonal antibody b78 using a combination of phage display, in vitro mutagenesis and molecular modelling. O'Connor KH; Banga JP; Darmanin C; El-Kabbani O; Mackay IR; Rowley MJ J Autoimmun; 2006 May; 26(3):172-81. PubMed ID: 16564157 [TBL] [Abstract][Full Text] [Related]
20. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis. Al-Bukhari TA; Radford PM; Bouras G; Davenport C; Trigwell SM; Bottazzo GF; Lai M; Schwartz HL; Tighe PJ; Todd I Clin Exp Immunol; 2002 Oct; 130(1):131-9. PubMed ID: 12296864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]